Page 141 - Study Group News Today

Accede al comunicado Latin America and the Caribbean Must Take Advantage of Historic Window of Opportunity and Reactivate Regional Integration, Focusing on the Ecological Transition, Aloizio Mercadante Proposed at ECLAC. Lee el texto completo aquí.

- Approximately 50% of Phase 3 PaTHway Trial patients with eGFR < 60 mL/min/1.73m2,the threshold for kidney dysfunction,receiving TransCon PTH experienced eGFR improvement to above 60 mL/min/1.73m2.

Email items for the Danville Register & Bees daily Mark your Calendar to news@registerbee.com.

Analysis of claims data showed reduced utilization and costs among patients with nonintensively treated type 2 diabetes (T2D) using self-monitoring of blood glucose compared with continuous glucose monitoring.

Evrysdi available to treat people of all ages with SMA in the European Union, including babies from birth1Approval is based on interim data from ongoing RAINBOWFISH trial showing majority of...

RAHWAY - Merck , known as MSD outside of the United States and Canada, today announced the initiation of the companys Phase 3 clinical program, CORALreef, for MK-0616, an investigational, oral...

Program plans to enroll approximately 17,000 participants across three global studies ...

Program plans to enroll approximately 17,000 participants across three global studies Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced the initiation of the company's Phase 3

Chinese President Xi Jinping addressed the 15th BRICS Summit on Wednesday.

Email items for the Danville Register & Bees daily Mark your Calendar to news@registerbee.com.